Pneumococcal Vaccines Market Report 2023: R&D Consistency Drives Sector Growth
The global Pneumococcal Vaccines Market is expected to grow at a 4.1% CAGR during the forecast period. The market is currently valued at US$ 8.9 billion in 2023. By 2033, the market for pneumococcal vaccines is expected to exceed US$ 13.3 billion. During the base year, Future Market Insights analysts recorded a historical market valuation of US$ 8.5 Billion for the concerned market. North America is expected to contribute a large revenue share to the global pneumococcal vaccines market over the forecast period due to rising healthcare expenditure, favourable reimbursement policies for pneumococcal vaccination, and the development of new multivalent pneumococcal vaccines. Furthermore, patients with Medicare in North America have no out-of-pocket costs for pneumococcal vaccines. The global market for pneumococcal vaccines is divided into three segments: product type, distribution channel, and region. Based on product type, the market is divided into two categories: pneumococcal conj...